Biogen (BIIB.US) and UCB's lupus new drug, daclizumab, late-stage trial successful, reversing early failures.
On Tuesday, BaiHealth and its Belgian partner UCB announced that the experimental lupus treatment drug Darzalex achieved the main goal in late-stage trials.
Express News | Astrazeneca Pharmaceuticals India Limited's stock price expanded by 10%.
Black Diamond Therapeutics' Lead Drug Candidate Shows Initial Anti-tumor Activity In Certain Type Of Lung Cancer Resistant To AstraZeneca's Drug
Black Diamond Reports Encouraging Phase 2 Data for BDTX-1535
AstraZeneca Antibody Drug Candidate Fails to Meet Overall Survival Goal in Breast Cancer
AstraZeneca's Cancer Drug Could Secure FDA Approval Despite Final Trial Let-Down